D. Massa , S.O. Giacchetti , C. Desmedt , M. Kok , P. Vigneri , M. Ragazzi , M. Lambertini , C. Vernieri , F. Piacentini , C. Criscitiello , L. Carbognin , A. Botticelli , L. Someil , C. Bouchez , G. Floris , F. Martorana , E. Lips , S. Lando , V. Guarneri , M.V. Dieci
{"title":"整合肿瘤浸润淋巴细胞和淋巴结状态对三阴性乳腺癌(TNBC)患者(pts)风险分层及新辅助治疗(NAT)后病理完全缓解(pCR)的影响","authors":"D. Massa , S.O. Giacchetti , C. Desmedt , M. Kok , P. Vigneri , M. Ragazzi , M. Lambertini , C. Vernieri , F. Piacentini , C. Criscitiello , L. Carbognin , A. Botticelli , L. Someil , C. Bouchez , G. Floris , F. Martorana , E. Lips , S. Lando , V. Guarneri , M.V. Dieci","doi":"10.1016/j.esmoop.2025.104557","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"10 ","pages":"Article 104557"},"PeriodicalIF":7.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2O Integrating tumor infiltrating lymphocytes and nodal status for risk stratification in patients (pts) with triple-negative breast cancer (TNBC) and pathological complete response (pCR) after neoadjuvant treatment (NAT)\",\"authors\":\"D. Massa , S.O. Giacchetti , C. Desmedt , M. Kok , P. Vigneri , M. Ragazzi , M. Lambertini , C. Vernieri , F. Piacentini , C. Criscitiello , L. Carbognin , A. Botticelli , L. Someil , C. Bouchez , G. Floris , F. Martorana , E. Lips , S. Lando , V. Guarneri , M.V. Dieci\",\"doi\":\"10.1016/j.esmoop.2025.104557\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11877,\"journal\":{\"name\":\"ESMO Open\",\"volume\":\"10 \",\"pages\":\"Article 104557\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESMO Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2059702925004260\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Open","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2059702925004260","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
2O Integrating tumor infiltrating lymphocytes and nodal status for risk stratification in patients (pts) with triple-negative breast cancer (TNBC) and pathological complete response (pCR) after neoadjuvant treatment (NAT)
期刊介绍:
ESMO Open is the online-only, open access journal of the European Society for Medical Oncology (ESMO). It is a peer-reviewed publication dedicated to sharing high-quality medical research and educational materials from various fields of oncology. The journal specifically focuses on showcasing innovative clinical and translational cancer research.
ESMO Open aims to publish a wide range of research articles covering all aspects of oncology, including experimental studies, translational research, diagnostic advancements, and therapeutic approaches. The content of the journal includes original research articles, insightful reviews, thought-provoking editorials, and correspondence. Moreover, the journal warmly welcomes the submission of phase I trials and meta-analyses. It also showcases reviews from significant ESMO conferences and meetings, as well as publishes important position statements on behalf of ESMO.
Overall, ESMO Open offers a platform for scientists, clinicians, and researchers in the field of oncology to share their valuable insights and contribute to advancing the understanding and treatment of cancer. The journal serves as a source of up-to-date information and fosters collaboration within the oncology community.